Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2014 (2014), Article ID 481823, 5 pages
http://dx.doi.org/10.1155/2014/481823
Case Report

Spontaneous Regression of a Carcinoid Tumor following Pregnancy

1Department of HPB and Transplant Surgery, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
2Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
3Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK

Received 6 July 2014; Accepted 5 December 2014; Published 21 December 2014

Academic Editor: Carlo Capella

Copyright © 2014 A. Sewpaul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Lubarsch, “Ueber den primären Krebs des Ileum nebst Bemerkungen über das gleichzeitige Vorkommen von Krebs und Tuberculose,” Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, vol. 111, no. 2, pp. 280–317, 1888. View at Publisher · View at Google Scholar · View at Scopus
  2. M. H. Kulke, A. B. Benson, E. Bergsland et al., “Neuroendocrine tumors,” Journal of the National Comprehensive Cancer Network, vol. 10, no. 6, pp. 724–764, 2012. View at Google Scholar
  3. M. H. Kulke and R. J. Mayer, “Carcinoid tumors,” The New England Journal of Medicine, vol. 340, no. 11, pp. 858–868, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. I. M. Modlin, K. D. Lye, and M. Kidd, “A 5-decade analysis of 13,715 carcinoid tumors,” Cancer, vol. 97, no. 4, pp. 934–959, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. K. E. Coan, R. J. Gray, R. T. Schlinkert, B. A. Pockaj, and N. Wasif, “Metastatic carcinoid tumors—are we making the cut?” The American Journal of Surgery, vol. 205, no. 6, pp. 642–646, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. K. E. Öberg, “The management of neuroendocrine tumours: current and future medical therapy options,” Clinical Oncology, vol. 24, no. 4, pp. 282–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Gedaly, M. F. Daily, D. Davenport et al., “Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database,” Archives of Surgery, vol. 146, no. 8, pp. 953–958, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Alsina, R. Marcos-Gragera, J. Capdevila et al., “Neuroendocrine tumors: a population-based study of incidence and survival in Girona province, 1994–2004,” Cancer Epidemiology, vol. 35, no. 6, pp. e49–e54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Lishner, “Cancer in pregnancy,” Annals of Oncology, vol. 14, supplement 3, pp. iii31–iii36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Pereg, G. Koren, and M. Lishner, “Cancer in pregnancy: gaps, challenges and solutions,” Cancer Treatment Reviews, vol. 34, no. 4, pp. 302–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Luosto, K. Koikkalainen, and P. Sipponen, “Spontaneous regression of a bronchial carcinoid tumour following pregnancy,” Annales Chirurgiae et Gynaecologiae Fenniae, vol. 63, no. 4, pp. 342–345, 1974. View at Google Scholar · View at Scopus
  12. T. Mizuno, M. Ishigaki, K. Nakajima et al., “Spontaneous remission of epstein-barr virus-positive diffuse large b-cell lymphoma of the elderly,” Case Reports in Oncology, vol. 6, no. 2, pp. 269–274, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mohsen, H. Ghanem, J. El-Bayoumi, and I. Tabbara, “Spontaneous regression of classical hodgkin lymphoma: a case report and review of the literature,” Clinical Advances in Hematology and Oncology, vol. 10, no. 11, pp. 762–766, 2012. View at Google Scholar · View at Scopus
  14. A. D. Janiszewska, S. Poletajew, and A. Wasiutyński, “Spontaneous regression of renal cell carcinoma,” Contemporary Oncology, vol. 17, no. 2, pp. 123–127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. A. Abubakr, T.-H. Chou, and B. G. Redman, “Spontaneous remission of renal cell carcinoma: a case report and immunological correlates,” Journal of Urology, vol. 152, no. 1, pp. 156–157, 1994. View at Google Scholar · View at Scopus
  16. S. Oquinena, F. Guillen-Grima, M. Iñarrairaegui, J. M. Zozaya, and B. Sangro, “Spontaneous regression of hepatocellular carcinoma: a systematic review,” European Journal of Gastroenterology & Hepatology, vol. 21, no. 3, pp. 254–257, 2009. View at Google Scholar
  17. J. Pritchard and J. A. Hickman, “Why does stage 4s neuroblastoma regress spontaneously?” The Lancet, vol. 344, no. 8926, pp. 869–870, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. T. C. Everson and W. H. Cole, Spontaneous Regression of Cancer, WB Saunders, Philadelphia, Pa, USA, 1966.
  19. G. B. Challis and H. J. Stam, “The spontaneous regression of cancer. A review of cases from 1900 to 1987,” Acta Oncologica, vol. 29, no. 5, pp. 545–550, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. P. D. Sawant, S. A. Nanivadekar, C. P. Shroff, A. Srinivas, and V. V. Dewoolkar, “Spontaneous regression of large gastric carcinoid,” Indian Journal of Gastroenterology, vol. 8, no. 4, pp. 289–290, 1989. View at Google Scholar · View at Scopus
  21. T. Jessy, “Immunity over inability: the spontaneous regression of cancer,” Journal of Natural Science, Biology and Medicine, vol. 2, no. 1, pp. 43–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. R. Balkwill, M. S. Naylor, and S. Malik, “Tumour necrosis factor as an anticancer agent,” European Journal of Cancer, vol. 26, no. 5, pp. 641–644, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Broder and J. E. Karp, “Progress against cancer,” Journal of Cancer Research and Clinical Oncology, vol. 121, no. 11, pp. 633–647, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Papac, “Spontaneous regression of cancer: possible mechanisms,” In Vivo, vol. 12, no. 6, pp. 571–578, 1998. View at Google Scholar · View at Scopus
  25. L. R. Kavoussi, S. R. Levine, D. Kadmon, and W. R. Fair, “Regression of metastatic renal cell carcinoma: a case report and literature review,” The Journal of Urology, vol. 135, no. 5, pp. 1005–1007, 1986. View at Google Scholar · View at Scopus
  26. L. M. Morton, T. M. Gibson, C. A. Clarke et al., “Risk of myeloid neoplasms after solid organ transplantation,” Leukemia, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Gorshtein, D. J. Gross, D. Barak et al., “Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity,” Cancer, vol. 118, no. 3, pp. 612–619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Schwaab, A. Schwarzer, B. Wolf et al., “Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with aldesleukin (interleukin 2) and IFN-α2a therapy in metastatic renal cell carcinoma patients,” Clinical Cancer Research, vol. 15, no. 15, pp. 4986–4992, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. K. Chakravarty and D. K. Sinha, “Pregnancy-induced antitumor cytotoxicity of T cell-rich fraction against mammary adenocarcinoma cells in rats,” Carcinogenesis, vol. 13, no. 12, pp. 2449–2452, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. R. B. Herberman and J. R. Ortaldo, “Natural killer cells: their roles in defenses against disease,” Science, vol. 214, no. 4516, pp. 24–30, 1981. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Manaseki and R. F. Searle, “Natural killer (NK) cell activity of first trimester human decidua,” Cellular Immunology, vol. 121, no. 1, pp. 166–173, 1989. View at Publisher · View at Google Scholar · View at Scopus
  32. W.-K. You, B. Sennino, C. W. Williamson et al., “VEGF and c-Met blockade amplify angiogenesis inhibition in Pancreatic Islet Cancer,” Cancer Research, vol. 71, no. 14, pp. 4758–4768, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Matsushita, N. Arima, H. Fujiwara et al., “Spontaneous regression associated with apoptosis in a patient with acute-type adult T-cell leukemia,” The American Journal of Hematology, vol. 61, no. 2, pp. 144–148, 1999. View at Publisher · View at Google Scholar